Keeping Track: Veklury NDA Arrives At US FDA; Olinvyk Sees Approval; MAb Filings By Regneron, Y-mAbs

 
• By Bridget Silverman
Keeping Track Feature image
Novel Opioid agonist Olinvyk Restricted To ‘Controlled Clinical Settings’

More from US FDA Performance Tracker

More from Regulatory Trackers